EMEA-000298-PIP01-08-M06 - paediatric investigation plan
peginterferon alfa-2a
PIPHuman
Roche Registration GmbH
Tel. +41 6169 79411
E-mail: global.paediatrics@roche.com
P/0143/2018: EMA decision of 7 May 2018 on the acceptance of a modification of an agreed paediatric investigation plan for peginterferon alfa-2a (Pegasys), (EMEA-000298-PIP01-08-M06)